[{"address1": "Dr. Neergaards Vej", "address2": "5th Floor", "city": "Horsholm", "zip": "2970", "country": "Denmark", "phone": "45 53 53 18 50", "website": "https://www.evaxion-biotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Christian  Kanstrup M.Sc.", "age": 51, "title": "Chief Executive Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 373000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andreas Holm Mattsson", "age": 47, "title": "Co-Founder and Chief AI & Culture Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 246000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jesper Nyegaard Nissen M.Sc.", "age": 52, "title": "CFO & COO", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 296000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Niels Iversen Moller M.D.", "age": 44, "title": "Co-Founder, VP of Business & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 120000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Birgitte  Rono Ph.D.", "age": 46, "title": "Chief Scientific Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 336000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. J\u00fcrgen  Langh\u00e4rig EMBA, Ph.D.", "title": "Head of Business Development & Member of Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.2, "open": 3.2, "dayLow": 3.08, "dayHigh": 3.4464, "regularMarketPreviousClose": 3.2, "regularMarketOpen": 3.2, "regularMarketDayLow": 3.08, "regularMarketDayHigh": 3.4464, "forwardPE": 323.0, "volume": 23200, "regularMarketVolume": 23200, "averageVolume": 700321, "averageVolume10days": 19010, "averageDailyVolume10Day": 19010, "marketCap": 15541339, "fiftyTwoWeekLow": 2.824, "fiftyTwoWeekHigh": 18.5, "priceToSalesTrailing12Months": 212.89505, "fiftyDayAverage": 4.17582, "twoHundredDayAverage": 7.991855, "currency": "USD", "enterpriseValue": 99765048, "floatShares": 24921730, "sharesOutstanding": 4811560, "sharesShort": 43017, "sharesShortPriorMonth": 19395, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.0089, "heldPercentInsiders": 0.16600001, "heldPercentInstitutions": 0.00934, "shortRatio": 0.15, "impliedSharesOutstanding": 37907000, "bookValue": -1.617, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -22125000, "trailingEps": -8.1, "forwardEps": 0.01, "lastSplitFactor": "1:10", "lastSplitDate": 1705881600, "enterpriseToRevenue": 1366.645, "enterpriseToEbitda": -4.634, "52WeekChange": -0.7288135, "SandP52WeekChange": 0.28136122, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "EVAX", "underlyingSymbol": "EVAX", "shortName": "Evaxion Biotech A/S", "longName": "Evaxion Biotech A/S", "firstTradeDateEpochUtc": 1612535400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "10e58503-7bd5-32f9-974e-d651a4f9f505", "messageBoardId": "finmb_319014926", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.23, "targetHighPrice": 20.0, "targetLowPrice": 7.0, "targetMeanPrice": 13.6, "targetMedianPrice": 13.81, "recommendationMean": 2.3, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 5583000, "totalCashPerShare": 0.191, "ebitda": -21530332, "totalDebt": 10870000, "quickRatio": 0.903, "currentRatio": 1.179, "totalRevenue": 73000, "revenuePerShare": 0.027, "returnOnAssets": -0.7947, "returnOnEquity": -12.38109, "freeCashflow": -10700750, "operatingCashflow": -17691000, "grossMargins": 1.0, "operatingMargins": -59.78082, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-02"}]